25 NFCR Affiliates Involved in 2024 AACR Annual Meeting
The National Foundation for Cancer Research (NFCR) is proud to have a presence at the 2024 American Association for Cancer Research (AACR) Annual Meeting, including several NFCR-funded researchers attending to share insights on the frontiers of oncology research. This highlights NFCR’s commitment to supporting innovators who are transforming the fight against cancer.
The AACR Annual Meeting brings together world-renowned thought leaders in cancer research from institutions across the globe. This annual event is a crucial gathering for the cancer community, providing a platform for patients, survivors, and professionals to exchange ideas, share experiences, and unveil their latest breakthroughs. NFCR’s role of supporting researchers at the meeting demonstrates our passion for identifying and supporting leaders whose bold discoveries shape the future of cancer science and medicine.
NFCR-supported researchers whose work will be highlighted include:
- Danny R. Welch, Ph.D., University of Kansas Cancer Center
- Suzanne L. Topalian, M.D., Johns Hopkins University
- Lisa Coussens, Ph.D., Oregon Health & Science University
- Elana Fertig, Ph.D., Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center
- J. Silvio Gutkind, Ph.D., University of California San Diego
- Massimo Cristofanilli, M.D., Weill Cornell Medicine
- Ling Huang, Ph.D., Henry Ford Cancer Institute
- Darren Carpizo, M.D., Ph.D., University of Rochester
- Ronald DePinho, M.D., University of Texas MD Anderson Cancer Center
- Daniel Von Hoff, M.D., Translational Genomics Research Institute (TGen)
- James P. Basilion, Ph.D., Case Western Reserve University
- John J. Letterio, M.D., Case Western Reserve University
- Kornelia Polyak, M.D., Ph.D., Dana-Farber Cancer Institute and Harvard Medical School
- Avery D. Posey, Ph.D., University of Pennsylvania
- Courtney W. Houchen, M.D., Oklahoma Health Sciences Center
- Aditya Bardia, M.D., Massachusetts General Hospital & Harvard Medical School
- Bert Vogelstein, M.D., Johns Hopkins University
- Xiang-Lei Yang, Ph.D., Scripps Research
- Siddhartha Mukherjee, M.D., D.PHIL, Columbia University
- Manijeh Goldberg, Ph.D., University of Massachusetts
7 Szent-Györgyi Prize for Progress in Cancer Research Winners will participate, including:
- Tak W. Mak, Ph.D., Princess Margaret Cancer Centre (2021 Co-Winner)
- Mark M. Davis, Ph.D., Stanford University School of Medicine (2021 Co-Winner)
- Steven A. Rosenberg, M.D., Ph.D., National Institutes of Health (2019)
- Douglas R. Lowy, M.D., National Institutes of Health (2018 Co-Winner)
- John T. Schiller, PhD, National Institutes of Health (2018 Co-Winner)
- Frederick W. Alt, PhD, Boston Children’s Hospital (2015)
- Ronald A. DePinho, M.D., University of Texas MD Anderson Cancer Center (2009)
Dr. Steven Rosenberg is being honored with the 2024 American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research.
Additionally, John T. Schiller, PhD and Frederick W. Alt, PhD will both be recognized as Fellows of the American Association for Cancer Research Academy.
A Proven Model Delivering Lifesaving Progress
For over half a century, NFCR has pioneered a uniquely integrative, collaborative research model designed to catalyze breakthroughs across the entire continuum of cancer research:
- Fostering cross-disciplinary teams that unite diverse expertise to spark new insights
- Supporting researchers focused on innovative prevention, early detection, and treatment
- Providing vital funding from high-risk discovery research to late-stage clinical trials
Donations to NFCR directly contribute to translating cancer research into cures. Our longstanding relationships with researchers, institutions, and initiatives ensure that contributions fuel high-impact projects led by accomplished innovators. Two prestigious AACR awards, the Daniel D. Von Hoff Award for cancer education and training impact and the Waun Ki Hong Award for translational/clinical excellence, have honored past NFCR-funded researchers, reflecting our commitment to supporting research visionaries. This year, the AACR Award for Lifetime Achievement in Cancer Research will be presented to Dr. Steven A. Rosenberg, who was also a celebrated Szent-Györgyi Prize winner in 2019.
Powering Tomorrow’s Cures Through Vision and Partnership
When donors support NFCR, they directly help translate cancer research into cures. Our long-standing relationships with pioneering researchers, institutions, and initiatives ensure contributions directly fuel high-impact projects led by the most accomplished innovators.
Looking ahead, NFCR’s collaborative model and focus on integrating insights from diverse disciplines position us optimally to drive progress by accelerating the translation of bold science into treatments that directly benefit patients worldwide.
With over 50 years advancing paradigm-shifting discoveries, NFCR remains boldly dedicated to supporting the field’s brightest minds, forging synergies, and transforming innovative research into cancer cures.
